Maravai Lifesciences Holdings Inc (MRVI) — Cash Flow-to-Debt Ratio
Maravai Lifesciences Holdings Inc (MRVI) has a Cash Flow-to-Debt Ratio of -0.04x as of September 2025, meaning its operating cash flow of $-15.15 Million could theoretically repay 0% of its total liabilities ($417.33 Million) in one year. Check Maravai Lifesciences Holdings Inc (MRVI) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Maravai Lifesciences Holdings Inc Cash Flow-to-Debt Ratio (2018–2024)
Historical debt coverage capacity for Maravai Lifesciences Holdings Inc across 7 annual periods. Also explore Maravai Lifesciences Holdings Inc asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Maravai Lifesciences Holdings Inc (2018–2024)
Year-by-year debt coverage analysis for Maravai Lifesciences Holdings Inc. For market capitalisation and broader financial context, see Maravai Lifesciences Holdings Inc (MRVI) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.02x | $7.46 Million | $431.04 Million | ▼ -90.4% |
| 2023 | 0.18x | $126.22 Million | $697.57 Million | ▼ -53.5% |
| 2022 | 0.39x | $535.98 Million | $1.38 Billion | ▲ +45.0% |
| 2021 | 0.27x | $368.57 Million | $1.37 Billion | ▲ +96.9% |
| 2020 | 0.14x | $152.19 Million | $1.12 Billion | ▲ +145.0% |
| 2019 | 0.06x | $24.11 Million | $433.17 Million | ▲ +11822.7% |
| 2018 | 0.00x | $-186.00K | $391.66 Million | — |